Search research articles
Contact Us
Filters
Showing results (1-10 of 254) with videos related to
Page
of 26
Sort By:
Journal of the American Academy of Dermatology
|
June 21, 2024
Response to Veenstra et al's "Benzoyl peroxide use in acne therapy: Evaluating the association with acute myeloid leukemia risk"
John S Barbieri
JAMA Dermatology
|
August 16, 2023
Temporal Trends in the Use of Systemic Medications for Acne From 2017 to 2020
John S Barbieri
JAMA Dermatology
|
July 19, 2023
Strengths and Limitations of Study Designs Using Administrative Data to Assess Incidence and Prevalence of Disease
John S Barbieri
JAMA Dermatology
|
April 17, 2024
Potential Role of Calcitonin Gene-Related Peptide Inhibitors in the Treatment of Rosacea Flushing and Erythema
John S Barbieri
JAMA
|
April 3, 2014
Basic science content in the USMLE Step 1
John S Barbieri
The British Journal of Dermatology
|
October 19, 2024
Levelling up outcomes in atopic dermatitis through personalized dosing of upadacitinib
John S Barbieri
Journal of the American Academy of Dermatology
|
February 15, 2023
Isotretinoin use for acne is not associated with an increased risk of migraine, fibromyalgia, multiple sclerosis, or neuropathy: A matched, retrospective cohort study
John S Barbieri
Journal of the American Academy of Dermatology
|
April 14, 2025
Response to Veenstra et al, "Benzoyl peroxide acne treatment shows no significant association with benzene-related cancers: A multicenter retrospective analysis"
John S Barbieri
JAMA Dermatology
|
June 11, 2020
Diet and Acne-Challenges of Translating Nutritional Epidemiologic Research Into Clinical Practice
John S Barbieri
JAMA Dermatology
|
April 13, 2026
Reframing and Corrections to Review of ICD Codes for Dermatologic Conditions
John S Barbieri
Page
of 26
Search research articles
Search
Showing results (1-10 of 254) with videos related to
Sort By:
Page
of 26
Journal of the American Academy of Dermatology
|
June 21, 2024
Response to Veenstra et al's "Benzoyl peroxide use in acne therapy: Evaluating the association with acute myeloid leukemia risk"
John S Barbieri
JAMA Dermatology
|
August 16, 2023
Temporal Trends in the Use of Systemic Medications for Acne From 2017 to 2020
John S Barbieri
JAMA Dermatology
|
July 19, 2023
Strengths and Limitations of Study Designs Using Administrative Data to Assess Incidence and Prevalence of Disease
John S Barbieri
JAMA Dermatology
|
April 17, 2024
Potential Role of Calcitonin Gene-Related Peptide Inhibitors in the Treatment of Rosacea Flushing and Erythema
John S Barbieri
JAMA
|
April 3, 2014
Basic science content in the USMLE Step 1
John S Barbieri
The British Journal of Dermatology
|
October 19, 2024
Levelling up outcomes in atopic dermatitis through personalized dosing of upadacitinib
John S Barbieri
Journal of the American Academy of Dermatology
|
February 15, 2023
Isotretinoin use for acne is not associated with an increased risk of migraine, fibromyalgia, multiple sclerosis, or neuropathy: A matched, retrospective cohort study
John S Barbieri
Journal of the American Academy of Dermatology
|
April 14, 2025
Response to Veenstra et al, "Benzoyl peroxide acne treatment shows no significant association with benzene-related cancers: A multicenter retrospective analysis"
John S Barbieri
JAMA Dermatology
|
June 11, 2020
Diet and Acne-Challenges of Translating Nutritional Epidemiologic Research Into Clinical Practice
John S Barbieri
JAMA Dermatology
|
April 13, 2026
Reframing and Corrections to Review of ICD Codes for Dermatologic Conditions
John S Barbieri
Page
of 26